Arrowhead Research Corp. Company Profile (NASDAQ:ARWR)

Analyst Ratings

Consensus Ratings for Arrowhead Research Corp. (NASDAQ:ARWR) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $9.69 (62.54% upside)

Analysts' Ratings History for Arrowhead Research Corp. (NASDAQ:ARWR)
Show:
DateFirmActionRatingPrice TargetActions
5/19/2016Chardan CapitalInitiated CoverageBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2016Jefferies GroupReiterated RatingHold$4.75View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Piper Jaffray Cos.Reiterated RatingOverweight$20.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015Royal Bank Of CanadaReiterated RatingHold$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2015Deutsche Bank AGDowngradeBuy -> Hold$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/31/2014 forward)

Earnings

Earnings History for Arrowhead Research Corp. (NASDAQ:ARWR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/10/2016Q216($0.37)($0.35)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2016Q1($0.41)($0.32)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/14/2015Q415($0.39)($0.42)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q315($0.38)($0.27)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q214($0.35)($0.33)$110.00 million$43.75 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2015Q114($0.34)($0.41)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/25/2014Q413($0.24)($0.33)$40.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014Q313($0.22)($0.22)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014($0.20)($0.31)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2014Q4($0.18)($0.33)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/18/2013Q4($0.23)($0.43)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q2 2013($0.41)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2013Q1 2013($0.33)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/20/2012Q4 2012($0.43)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Arrowhead Research Corp. (NASDAQ:ARWR)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.44)($0.35)($0.39)
Q2 20163($0.42)($0.37)($0.39)
Q3 20162($0.40)($0.38)($0.39)
Q4 20161($0.32)($0.32)($0.32)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Arrowhead Research Corp. (NASDAQ:ARWR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Arrowhead Research Corp. (NASDAQ:ARWR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/30/2015Kenneth Allen MyszkowskiCFOSell23,347$6.13$143,117.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2015Mauro FerrariDirectorBuy400$7.62$3,048.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/9/2015Mauro FerrariDirectorBuy1,900$6.19$11,761.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015David L LewisInsiderSell15,000$8.01$120,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2014Christopher Richard AnzaloneCEOBuy16,000$6.32$101,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Charles MckenneyDirectorSell2,500$14.70$36,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/30/2014David L LewisInsiderSell15,000$15.02$225,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/26/2014Douglas B GivenDirectorSell2,000$15.24$30,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2014Charles MckenneyDirectorSell22,000$14.32$315,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2014Kenneth Allen MyszkowskiCFOSell16,000$18.77$300,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/7/2014Edward W FrykmanDirectorSell3,148$15.98$50,305.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Arrowhead Research Corp. (NASDAQ:ARWR)
DateHeadline
07/25/16 07:24 AMArrowhead Research Corporation (NASDAQ:ARWR) Updated Price Targets - FTSE News
07/22/16 10:47 AMEarnings Focus and Crowd Sourced Sentiment Review for Arrowhead Research Corporation (NASDAQ:ARWR) - TGP
07/22/16 07:20 AMArrowhead Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARWR-US : July 22, 2016 -
07/19/16 02:35 PMEquity Roundup: Stock Performance Focus on Arrowhead Research Corporation (NASDAQ:ARWR) - Press Telegraph
07/16/16 02:34 PMCrowd Rating and Earnings Recap for Arrowhead Research Corporation (NASDAQ:ARWR) - Telanagana Press
07/14/16 11:29 AMArrowhead Research Corporation (NASDAQ:ARWR) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/12/16 05:58 AMCompany Stock Focus for Arrowhead Research Corporation (NASDAQ:ARWR): Which Way Will Shares Head? - Press Telegraph
07/12/16 05:58 AMTrading Performance and Target Watch for Arrowhead Research Corporation (NASDAQ:ARWR) - Press Telegraph
07/11/16 07:40 AMArrowhead Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ARWR-US : July 11, 2016 -
07/07/16 02:37 PMSentiment Report: Arrowhead Research Corp (NASDAQ:ARWR) - Press Telegraph
07/07/16 10:31 AMArrowhead Research Corporation (NASDAQ:ARWR) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/06/16 07:24 AMStock Rating Watch and Earnings Insight for Arrowhead Research Corporation (NASDAQ:ARWR) - Press Telegraph
07/06/16 07:01 AMArrowhead Pharmaceuticals to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference - [at noodls] - PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that president and chief executive officer Christopher Anzalone, Ph.D., will present at Cantor Fitzgerald's ...
07/06/16 06:30 AMArrowhead Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference - [Business Wire] - Arrowhead Pharmaceuticals Inc. today announced that president and chief executive officer Christopher Anzalone, Ph.D., will present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on July 13, 2016 at 10:45 a.m.
07/05/16 02:34 PMCan Arrowhead Research Corporation (NASDAQ:ARWR) Improve on the Earnings Front? - Engelwood Daily
07/02/16 02:37 PMCan Arrowhead Research Corporation (NASDAQ:ARWR) Keep Up with Analyst Expectations? - Investor Newswire
07/01/16 04:54 PMETF’s with exposure to Arrowhead Pharmaceuticals, Inc. : July 1, 2016 -
07/01/16 02:37 PMNew Broker Ratings For Arrowhead Research Corporation (NASDAQ:ARWR) - FTSE News
07/01/16 02:37 PMArrowhead Research Corporation (NASDAQ:ARWR) Company Rating and Target Watch - Telanagana Press
06/29/16 02:34 PMShare Update and Earnings Review for Arrowhead Research Corporation (NASDAQ:ARWR) - Press Telegraph
06/27/16 02:54 PMArrowhead Research Corporation (NASDAQ:ARWR) Earnings Glance and Target Price Review - Engelwood Daily
06/27/16 08:05 AMArrowhead Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARWR-US : June 27, 2016 -
06/27/16 07:19 AMArrowhead Research Corporation (NASDAQ:ARWR) Broker Price Targets For The Coming Week - Fiscal Standard
06/21/16 02:32 PMRecently Issued Stock Ratings For Arrowhead Research Corporation (NASDAQ:ARWR) - Fiscal Standard
06/19/16 07:17 AMThis Weeks Broker Views For Arrowhead Research Corporation (NASDAQ:ARWR) - Fiscal Standard
06/17/16 10:53 AMArrowhead Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ARWR) : June 17, 2016 -
06/15/16 07:22 AMArrowhead Research Corporation (NASDAQ:ARWR) Current Analyst Ratings - Fiscal Standard
06/15/16 07:10 AMArrowhead Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARWR-US : June 15, 2016 -
06/09/16 06:49 AMArrowhead Pharmaceuticals Initiates Phase 1/2 Single and Multiple Dose Study of Hepatitis B Candidate ARC-521 - [at noodls] - PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it initiated a Phase 1/2 study of ARC-521, the company's second RNAi-based investigational medicine ...
06/09/16 06:31 AM7:31 am Arrowhead initiates a Phase 1/2 study of ARC-521 for the treatment of chronic hepatitis B virus infection -
06/03/16 02:38 PMArrowhead Research Corporation (NASDAQ:ARWR) Stock Update & Estimates - Stock Tick Tock
06/03/16 11:05 AMArrowhead Research Corporation (NASDAQ:ARWR) Quarterly EPS Estimate At $-0.35 - Investor Newswire
06/03/16 11:05 AMBuy, Sell Or Hold Rating For Arrowhead Research Corporation (NASDAQ:ARWR)? - Share Trading News
06/03/16 06:45 AMArrowhead Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference - [at noodls] - PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that chief operating officer and head of R&D Bruce Given, M.D., will present at the Jefferies 2016 Healthcare ...
06/01/16 02:40 PMArrowhead Research Corporation (NASDAQ:ARWR) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Arrowhead Research Corporation (NASDAQ:ARWR) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Arrowhead Research Corporation (NASDAQ:ARWR). The latest reports which are currently in issue on Wednesday 1st of June state 0 analysts have a rating of “strong buy”, ...Arrowhead Pharmaceuticals Incorporated (NASDAQ:ARWR) Sellers Covered 1.99% of Their ShortsFranklin Independentall 2 news articles »
06/01/16 11:00 AMStock Review and Earnings Check on Arrowhead Research Corporation (NASDAQ:ARWR) - HNN - Stock Review and Earnings Check on Arrowhead Research Corporation (NASDAQ:ARWR)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Arrowhead Research Corporation (NASDAQ:ARWR) to report quarterly EPS of $-0.37. The company's next earnings report is expected to be ...and more »
05/30/16 07:18 AMStock Rating Review for Arrowhead Research Corporation (NASDAQ:ARWR) - HNN - Stock Rating Review for Arrowhead Research Corporation (NASDAQ:ARWR)HNNInvestors may choose to follow the views of professional Wall Street analysts that regularly track the company. Covering equity analysts presently have a consensus stock rating of 1.67 on shares of Arrowhead Research Corporation (NASDAQ:ARWR).and more »
05/26/16 07:20 AMChardan Capital Initiates Coverage on Arrowhead Research Corp to Buy - Trade Calls - Chardan Capital Initiates Coverage on Arrowhead Research Corp to BuyTrade CallsChardan Capital Initiates Coverage on Arrowhead Research Corp(NASDAQ:ARWR). The shares have been rated Buy. The rating by Chardan Capital was issued on May 19, 2016. Arrowhead Research Corp (ARWR) made into the market gainers list on ...
05/25/16 09:09 PMArrowhead Research Corporation (NASDAQ:ARWR) EPS Estimate At $-0.37 - RealistInvestor.com - Arrowhead Research Corporation (NASDAQ:ARWR) EPS Estimate At $-0.37RealistInvestor.comThe EPS projection of Arrowhead Research Corporation (NASDAQ:ARWR) for quarter ended 2016-09-30 is $-0.37. A week earlier, the EPS target was $-0.37 against target of $-0.37, a month earlier. This target stood at $-0.37 60 days ago against estimate of ...
05/25/16 07:14 AMEarnings Review and Stock Rundown for Arrowhead Research Corporation (NASDAQ:ARWR) - Wall Street Hints and News - Earnings Review and Stock Rundown for Arrowhead Research Corporation (NASDAQ:ARWR)Wall Street Hints and NewsEarnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Arrowhead Research Corporation (NASDAQ:ARWR) to post quarterly EPS of $-0.38. The company is expected to next publish earnings on or ...and more »
05/24/16 09:19 PMTarget Check and Stock Performance Recap Arrowhead Research Corporation (NASDAQ:ARWR) - Wall Street Hints and News - Target Check and Stock Performance Recap Arrowhead Research Corporation (NASDAQ:ARWR)Wall Street Hints and NewsIn recent session activity, Arrowhead Research Corporation (NASDAQ:ARWR) shares have traded +2.48%. Monitoring the stock price relative to moving averages may provide enhanced perspective on share performance. After a recent check, the stock has ...and more »
05/23/16 08:55 AMStock Rating Review for Arrowhead Research Corporation (NASDAQ:ARWR) - Wall Street Hints and News - Stock Rating Review for Arrowhead Research Corporation (NASDAQ:ARWR)Wall Street Hints and NewsInvestors may choose to follow the views of professional Wall Street analysts that regularly track the company. Covering equity analysts presently have a consensus stock rating of 1.5 on shares of Arrowhead Research Corporation (NASDAQ:ARWR).and more »
05/22/16 08:43 AMCan Arrowhead Pharmaceuticals Inc's Tomorrow Be Different? The Stock Increases Again - Wall Street Hints and News - Trade CallsCan Arrowhead Pharmaceuticals Inc's Tomorrow Be Different? The Stock Increases AgainWall Street Hints and NewsOut of 4 analysts covering Arrowhead Research Corp (NASDAQ:ARWR), 0 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means NaN are positive. $13 is the highest target while $4.75 is the lowest. The $9.69 average target is 195.20% above today's ($5.42) ...Is it Time to Cash in Profits on Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)Franklin Independentall 3 news articles »
05/21/16 07:23 AMThe Market In 5 Minutes: The Oscars Of Fintech Is Coming - Benzinga - BenzingaThe Market In 5 Minutes: The Oscars Of Fintech Is ComingBenzingaBelow is a tool used by the Benzinga News Desk each trading day -- it's a look at everything happening in the market, in five minutes. Apply for daily AM access by clicking here or email [email protected] more »
05/21/16 07:23 AMRevenue Update on Arrowhead Research Corp(NASDAQ:ARWR) - Trade Calls - Trade CallsRevenue Update on Arrowhead Research Corp(NASDAQ:ARWR)Trade CallsArrowhead Research Corp(NASDAQ:ARWR) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on May 10, 2016. Company reported revenue of $43.75K. Analysts estimated a revenue of $70.00K. Earnings ...
05/20/16 12:00 PMARWR: Update on Financials for Fiscal Second Quarter Ended March 31, 2016 -
05/19/16 12:04 PMARROWHEAD PHARMACEUTICALS, INC. Financials -
05/19/16 05:09 AMCoverage initiated on Arrowhead by Chardan Capital Markets -
05/18/16 08:12 AMShare Recap and Earnings Focus on Arrowhead Research Corporation (NASDAQ:ARWR) - Wall Street Hints and News - Share Recap and Earnings Focus on Arrowhead Research Corporation (NASDAQ:ARWR)Wall Street Hints and NewsAnalysts and investors are usually very focused on company earnings numbers when they are released. Company earnings are a good way to evaluate the profitability of the company. Presently, covering analysts are anticipating Arrowhead Research ...and more »
05/17/16 09:07 PMShare Performance and Target Price Review for Arrowhead Research Corporation (NASDAQ:ARWR) - Wall Street Hints and News - Share Performance and Target Price Review for Arrowhead Research Corporation (NASDAQ:ARWR)Wall Street Hints and NewsLooking at stock activity from multiple angles may be of benefit when examining share performance. Investors have the ability to focus in on short or long term share performance. During the most recent trading session, Arrowhead Research Corporation ...and more »

Social

About Arrowhead Research Corp.

Arrowhead Research Corp. logoArrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, is a biopharmaceutical company. The Company is engaged in developing RiboNucleic Acid interference (RNAi) therapeutics. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA. ARC-520 is designed to treat chronic hepatitis B virus (HBV) infection. ARC-AAT is an unlocked nucleobase analog containing RNAi-based therapeutic for the treatment of liver disease associated with alpha-1 antitrypsin deficiency (AATD). Its Dynamic Polyconjugate platform is an RNAi delivery system that promotes high levels of target gene knockdown. ARC-F12 is an RNAi-based therapeutic designed to reduce the production of factor 12 for providing a prophylactic treatment for hereditary angioedema and thromboembolic diseases. ARC-LPA is an RNAi-based therapeutic designed to reduce production of apolipoprotein A. ARC-HIF2 is an RNAi-based therapeutic designed to reduce the production of hypoxia-inducible factor 2a.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ARWR
  • CUSIP:
Key Metrics:
  • Previous Close: $5.98
  • 50 Day Moving Average: $5.68
  • 200 Day Moving Average: $5.06
  • P/E Ratio: N/A
  • P/E Growth: -0.58
  • Market Cap: $357.36M
  • Beta: 2.36
  • Current Year EPS Consensus Estimate: $-1.41 EPS
  • Next Year EPS Consensus Estimate: $-1.43 EPS
Additional Links:
Arrowhead Research Corp. (NASDAQ:ARWR) Chart for Sunday, July, 31, 2016